Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
News Alert: FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system
Thursday, August 25, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system

This latest recall was initiated because electrical faults could cause the batteries to stop working, which leads to a risk of serious injury or death.

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces a new recall of more than 23,000 batteries for Medtronic’s HVAD system

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
This latest recall was initiated because electrical faults could cause the batteries to stop working, which leads to a risk of serious injury or death.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

News Alert: FDA announces recall of Cardiohelp emergency drives due to serious risks
Structural Heart Disease: Non-invasive ultrasound therapy | AFib guidelines include new LAAO recommendation
Medtronic backs out of $738M deal | Cardiologist at center of alleged scheme | Dapagliflozin & HF symptoms
Aetna urged to change 'restrictive' policies | Vegan diet linked to key benefits in identical twin study | New data on statins
TAVR Highlights: 3-in-1 guidewire impresses | Treating minimally symptomatic patients | Tracking PPM | Much more!
Cardiac CT's continued rise | Is corporate ownership bad for patient care? | New TAVR guidewire impresses cardiologists
Roche spends $2.7B to acquire new drugs for obesity, diabetes | 19 important topics for AFib experts to study

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …6
    • Page 7
    • Page 8
    • Page 9
    • Current page 10
    • Page 11
    • Page 12
    • Page 13
    • Page 14 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme